STOCK TITAN

[Form 4] MARIMED INC. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Mario Pinho, Chief Financial Officer of Marimed Inc. (MRMD), reported transactions dated 09/15/2025. The filing shows 16,076 restricted stock units (RSUs) treated as acquired and convertible one-for-one into common shares, and 4,574 shares withheld to satisfy tax withholding at a reported price of $0.1374 per share. Following the reported activity the filing lists 157,386 shares beneficially owned directly by the reporting person. The RSUs were originally granted May 9, 2025, and remaining RSUs vest on December 15, 2025, under the award agreement. The Form 4 was signed 09/16/2025.

Mario Pinho, Direttore Finanziario di Marimed Inc. (MRMD), ha riportato operazioni datate 15/09/2025. La dichiarazione mostra 16.076 unità azionarie vincolate (RSU) trattate come acquisite e convertibili una per una in azioni ordinarie, e 4.574 azioni trattenute per soddisfare la ritenuta fiscale a un prezzo riportato di $0,1374 per azione. A seguito dell'attività riportata, la dichiarazione elenca 157.386 azioni detenute direttamente dalla persona che segnala. Le RSU sono state originariamente concesse il 9 maggio 2025, e le RSU rimanenti maturano il 15 dicembre 2025, secondo l'accordo di premio. Il Form 4 è stato firmato il 16/09/2025.
Mario Pinho, Director Financiero de Marimed Inc. (MRMD), informó operaciones con fecha 15/09/2025. La presentación muestra 16.076 unidades de acciones restringidas (RSU) tratadas como adquiridas y convertibles una por una en acciones ordinarias, y 4.574 acciones retenidas para satisfacer la retención de impuestos a un precio reportado de $0,1374 por acción. Tras la actividad reportada, la presentación enumera 157.386 acciones de titularidad directa de la persona que reporta. Las RSU se concedieron originalmente el 9 de mayo de 2025, y las RSU restantes vencerán el 15 de diciembre de 2025, según el acuerdo de adjudicación. El Formulario 4 fue firmado el 16/09/2025.
마리오 핀오(Mario Pinho), Marimed Inc.의 최고재무책임자(CFO)(MRMD), 2025년 9월 15일 자 거래를 보고했습니다. 공시에는 16,076주의 제한주식단위(RSU)가 취득된 것으로 처리되었고, 1대1로 보통주로 전환 가능하며, 세금 원천징수를 충족하기 위해 4,574주가 보유액으로 차감되었고, 주당 보고 가격은 $0.1374입니다. 보고된 활동 이후, 공시는 보고자가 직접 소유한 주식 157,386주를 기재합니다. RSU는 2025년 5월 9일에 원래 부여되었으며 남아 있는 RSU는 2025년 12월 15일에 취득권이 만료됩니다(상여금 계약에 따라). 4형 양식(Form 4)은 2025년 9월 16일에 서명되었습니다.
Mario Pinho, directeur financier de Marimed Inc. (MRMD), a signalé des transactions datées du 15/09/2025. Le dépôt indique 16 076 unités d’actions restreintes (RSU) traitées comme acquises et convertibles une pour une en actions ordinaires, et 4 574 actions retenues pour satisfaire à la retenue d'impôt à un prix déclaré de 0,1374 $ par action. Suite à l’activité signalée, le dépôt répertorie 157 386 actions détenues directement par la personne qui déclare. Les RSU ont été accordées initialement le 9 mai 2025, et les RSU restantes vestent le 15 décembre 2025, conformément à l’accord de attribution. Le Formulaire 4 a été signé le 16/09/2025.
Mario Pinho, Chief Financial Officer von Marimed Inc. (MRMD), meldete Transaktionen mit Datum 15.09.2025. Die Einreichung zeigt 16.076 eingeschränkte Aktieneinheiten (RSUs), die als erworben behandelt werden und eins-zu-eins in Stammaktien umwandelbar sind, sowie 4.574 Aktien, die zur Deckung der Steuern einbehalten wurden, zu einem berichteten Preis von 0,1374 $ pro Aktie. Nach der gemeldeten Aktivität listet die Einreichung direkt vom meldepflichtigen Person gehaltene Aktien in Höhe von 157.386. Die RSUs wurden ursprünglich am 9. Mai 2025 gewährt und verbleibende RSUs vesten am 15. Dezember 2025 gemäß der Preisvereinbarung. Das Form 4 wurde am 16.09.2025 unterzeichnet.
ماريو فينو، المدير المالي لشركة Marimed Inc. (MRMD)، أبلغ عن صفقات بتاريخ 15/09/2025. تُظهر الملفات أن 16,076 وحدة أسهم مقيدة (RSU) مُعالجة كأنه قد تم اكتسابها وقابلة للتحويل واحد لواحد إلى أسهم عادية، و4,574 سهمًا محجوزًا لتلبية احتجاز الضريبة بسعر مُبلّغ عنه قدره 0.1374 دولار للسهم. بعد النشاط المبلغ عنه، تُدرِج المطالبة 157,386 سهمًا مملوكًا مباشرة من قبل الشخص المبلغ. تم منح RSU في الأصل في 9 مايو 2025، وتستحق RSU المتبقية في 15 ديسمبر 2025، وفقًا لاتفاق المكافأة. تم توقيع النموذج Form 4 في 16/09/2025.
马里奥·平诺(Mario Pinho),Marimed Inc.(MRMD)的首席财务官,报告了日期为2025年9月15日的交易。该披露显示16,076份受限股票单位(RSU)被视为已取得,并可按一对一转换为普通股,且为满足税收代扣而扣留了4,574股,披露价格为每股0.1374美元。在所披露的活动之后,披露列出报告人直接持有的共计157,386股。RSU最初于2025年5月9日授予,剩余的RSU将于2025年12月15日归属,依据奖励协议。Form 4于2025年9月16日签署。
Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine insider vesting and tax-withholding; minor share movement with no revenue or debt implications.

The Form 4 documents a standard executive equity vesting event: 16,076 RSUs converted on 09/15/2025 and 4,574 shares withheld to meet tax obligations at $0.1374 per share. The net change reduces outstanding shares held by the insider modestly but does not indicate open-market purchases or sales beyond withholding. This is an expected compensation-related transaction and should be viewed as operational equity management rather than a signal of company-wide material change.

TL;DR: Compensation vesting followed award terms; disclosure aligns with Section 16 requirements.

The report discloses that RSUs granted May 9, 2025, vested in part on 09/15/2025 with remaining RSUs scheduled to vest December 15, 2025, consistent with award agreement timing. The withholding of 4,574 shares for taxes is a common practice to satisfy tax withholding obligations. The filing appears complete for the disclosed transactions and was timely signed on 09/16/2025, meeting routine compliance expectations.

Mario Pinho, Direttore Finanziario di Marimed Inc. (MRMD), ha riportato operazioni datate 15/09/2025. La dichiarazione mostra 16.076 unità azionarie vincolate (RSU) trattate come acquisite e convertibili una per una in azioni ordinarie, e 4.574 azioni trattenute per soddisfare la ritenuta fiscale a un prezzo riportato di $0,1374 per azione. A seguito dell'attività riportata, la dichiarazione elenca 157.386 azioni detenute direttamente dalla persona che segnala. Le RSU sono state originariamente concesse il 9 maggio 2025, e le RSU rimanenti maturano il 15 dicembre 2025, secondo l'accordo di premio. Il Form 4 è stato firmato il 16/09/2025.
Mario Pinho, Director Financiero de Marimed Inc. (MRMD), informó operaciones con fecha 15/09/2025. La presentación muestra 16.076 unidades de acciones restringidas (RSU) tratadas como adquiridas y convertibles una por una en acciones ordinarias, y 4.574 acciones retenidas para satisfacer la retención de impuestos a un precio reportado de $0,1374 por acción. Tras la actividad reportada, la presentación enumera 157.386 acciones de titularidad directa de la persona que reporta. Las RSU se concedieron originalmente el 9 de mayo de 2025, y las RSU restantes vencerán el 15 de diciembre de 2025, según el acuerdo de adjudicación. El Formulario 4 fue firmado el 16/09/2025.
마리오 핀오(Mario Pinho), Marimed Inc.의 최고재무책임자(CFO)(MRMD), 2025년 9월 15일 자 거래를 보고했습니다. 공시에는 16,076주의 제한주식단위(RSU)가 취득된 것으로 처리되었고, 1대1로 보통주로 전환 가능하며, 세금 원천징수를 충족하기 위해 4,574주가 보유액으로 차감되었고, 주당 보고 가격은 $0.1374입니다. 보고된 활동 이후, 공시는 보고자가 직접 소유한 주식 157,386주를 기재합니다. RSU는 2025년 5월 9일에 원래 부여되었으며 남아 있는 RSU는 2025년 12월 15일에 취득권이 만료됩니다(상여금 계약에 따라). 4형 양식(Form 4)은 2025년 9월 16일에 서명되었습니다.
Mario Pinho, directeur financier de Marimed Inc. (MRMD), a signalé des transactions datées du 15/09/2025. Le dépôt indique 16 076 unités d’actions restreintes (RSU) traitées comme acquises et convertibles une pour une en actions ordinaires, et 4 574 actions retenues pour satisfaire à la retenue d'impôt à un prix déclaré de 0,1374 $ par action. Suite à l’activité signalée, le dépôt répertorie 157 386 actions détenues directement par la personne qui déclare. Les RSU ont été accordées initialement le 9 mai 2025, et les RSU restantes vestent le 15 décembre 2025, conformément à l’accord de attribution. Le Formulaire 4 a été signé le 16/09/2025.
Mario Pinho, Chief Financial Officer von Marimed Inc. (MRMD), meldete Transaktionen mit Datum 15.09.2025. Die Einreichung zeigt 16.076 eingeschränkte Aktieneinheiten (RSUs), die als erworben behandelt werden und eins-zu-eins in Stammaktien umwandelbar sind, sowie 4.574 Aktien, die zur Deckung der Steuern einbehalten wurden, zu einem berichteten Preis von 0,1374 $ pro Aktie. Nach der gemeldeten Aktivität listet die Einreichung direkt vom meldepflichtigen Person gehaltene Aktien in Höhe von 157.386. Die RSUs wurden ursprünglich am 9. Mai 2025 gewährt und verbleibende RSUs vesten am 15. Dezember 2025 gemäß der Preisvereinbarung. Das Form 4 wurde am 16.09.2025 unterzeichnet.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Pinho Mario

(Last) (First) (Middle)
C/O MARIMED INC.
10 OCEANA WAY

(Street)
NORWOOD MA 02062

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock 09/15/2025 M 16,076 A $0(1) 161,960 D
Common stock 09/15/2025 F 4,574(2) D $0.1374 157,386 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (RSU) (1) 09/15/2025 M 16,076 (3) (3) Common Stock, par value $.001 per share 16,076 $0 16,075 D
Explanation of Responses:
1. RSUs convert to shares of common stock on a one-for-one basis.
2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
3. The RSUs were granted on May 9, 2025; the remaining RSUs will vest on December 15, 2025 in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
Remarks:
/s/ Mario Pinho 09/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did MRMD insider Mario Pinho report on Form 4?

Answer: The Form 4 reports conversion/vesting of 16,076 RSUs and withholding of 4,574 shares for taxes, both dated 09/15/2025.

How many shares does Mario Pinho beneficially own after the reported transactions?

Answer: The filing lists 157,386 shares beneficially owned following the reported transactions.

When were the RSUs granted and when do remaining RSUs vest?

Answer: The RSUs were granted on May 9, 2025; remaining RSUs will vest on December 15, 2025 per the award agreement.

What was the price reported for the shares withheld for taxes?

Answer: The shares withheld are reported with a price of $0.1374 per share.

What disclosure role and filing date are shown on the Form 4?

Answer: Mario Pinho is reported as Chief Financial Officer and the Form 4 was signed on 09/16/2025.
Marimed

OTC:MRMD

MRMD Rankings

MRMD Latest News

MRMD Latest SEC Filings

MRMD Stock Data

56.49M
280.32M
14.7%
0.24%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Norwood